In this study, siRNA was used to downregulate the high expression of the Emi1 gene in breast cancer cells, inhibit downstream signal transduction and achieve the effect of downregulating the expression of downstream target genes, thereby decreasing the proliferation and invasion ability of tumours. This evidence concerns the gene FBXO5 and breast cancer.